These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 18039111

  • 21. Folding proteins in fatal ways.
    Selkoe DJ.
    Nature; 2003 Dec 18; 426(6968):900-4. PubMed ID: 14685251
    [Abstract] [Full Text] [Related]

  • 22. Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships.
    Bemporad F, Chiti F.
    Chem Biol; 2012 Mar 23; 19(3):315-27. PubMed ID: 22444587
    [Abstract] [Full Text] [Related]

  • 23. Neurodegeneration in familial amyloidotic polyneuropathy.
    Gasperini RJ, Small DH.
    Clin Exp Pharmacol Physiol; 2012 Aug 23; 39(8):680-3. PubMed ID: 21916933
    [Abstract] [Full Text] [Related]

  • 24. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
    Rockenstein E, Crews L, Masliah E.
    Adv Drug Deliv Rev; 2007 Sep 30; 59(11):1093-102. PubMed ID: 17869376
    [Abstract] [Full Text] [Related]

  • 25. Alpha 1-antichymotrypsin in brain aging and disease.
    Abraham CR, Potter H.
    Prog Clin Biol Res; 1989 Sep 30; 317():1037-48. PubMed ID: 2513582
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of amyloid formation.
    Härd T, Lendel C.
    J Mol Biol; 2012 Aug 24; 421(4-5):441-65. PubMed ID: 22244855
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Neurodegenerative conformational disease and its molecular bases].
    Li WW, Cai DF, Ren HM.
    Sheng Li Ke Xue Jin Zhan; 2006 Apr 24; 37(2):97-102. PubMed ID: 16850610
    [Abstract] [Full Text] [Related]

  • 29. Natural polyphenols binding to amyloid: a broad class of compounds to treat different human amyloid diseases.
    Ngoungoure VL, Schluesener J, Moundipa PF, Schluesener H.
    Mol Nutr Food Res; 2015 Jan 24; 59(1):8-20. PubMed ID: 25167846
    [Abstract] [Full Text] [Related]

  • 30. Solid-state NMR reveals differences in the packing arrangements of peptide aggregates derived from the aortic amyloid polypeptide medin.
    Davies HA, Madine J, Middleton DA.
    J Pept Sci; 2012 Jan 24; 18(1):65-72. PubMed ID: 22102261
    [Abstract] [Full Text] [Related]

  • 31. Hidden amyloidoses.
    Diringer H.
    Exp Clin Immunogenet; 1992 Jan 24; 9(4):212-29. PubMed ID: 1364008
    [Abstract] [Full Text] [Related]

  • 32. Structures for amyloid fibrils.
    Makin OS, Serpell LC.
    FEBS J; 2005 Dec 24; 272(23):5950-61. PubMed ID: 16302960
    [Abstract] [Full Text] [Related]

  • 33. Implications of protein structure instability: from physiological to pathological secondary structure.
    Sukhanova A, Poly S, Shemetov A, Bronstein I, Nabiev I.
    Biopolymers; 2012 Aug 24; 97(8):577-88. PubMed ID: 22605549
    [Abstract] [Full Text] [Related]

  • 34. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N, Zhou M, Giralt E, Robinson CV, Dobson CM.
    Acc Chem Res; 2010 Aug 17; 43(8):1072-9. PubMed ID: 20557067
    [Abstract] [Full Text] [Related]

  • 35. Amyloid toxicity and platelet-activating factor signaling.
    Sirangelo I, Irace G, Balestrieri ML.
    J Cell Physiol; 2013 Jun 17; 228(6):1143-8. PubMed ID: 23169529
    [Abstract] [Full Text] [Related]

  • 36. Molecular pathogenesis of protein misfolding diseases: pathological molecular environments versus quality control systems against misfolded proteins.
    Naiki H, Nagai Y.
    J Biochem; 2009 Dec 17; 146(6):751-6. PubMed ID: 19643812
    [Abstract] [Full Text] [Related]

  • 37. [Neurodegenerative amyloidoses: the yeast model].
    Vishnevskaia AB, Kushnirov VV, Ter-Avanesian MD.
    Mol Biol (Mosk); 2007 Dec 17; 41(2):346-54. PubMed ID: 17514901
    [Abstract] [Full Text] [Related]

  • 38. Brain iron accumulation in aging and neurodegenerative disorders.
    Hagemeier J, Geurts JJ, Zivadinov R.
    Expert Rev Neurother; 2012 Dec 17; 12(12):1467-80. PubMed ID: 23237353
    [Abstract] [Full Text] [Related]

  • 39. Probing the origins, diagnosis and treatment of amyloid diseases using antibodies.
    Dumoulin M, Dobson CM.
    Biochimie; 2004 Dec 17; 86(9-10):589-600. PubMed ID: 15556268
    [Abstract] [Full Text] [Related]

  • 40. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K, Robotka H, Toldi J, Vécsei L.
    J Neurol Sci; 2007 Jun 15; 257(1-2):221-39. PubMed ID: 17462670
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.